On the public citation graph
Regulatory Frameworks for Clinical Trial Data Sharing: Scoping Review
0 signed · 83 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2014.850openalex-snapshot
Approaches and Costs for Sharing Clinical Research Data
inferredcites →https://doi.org/10.1001/jama.2015.481openalex-snapshot
Clinical Trial Data: Share and Share Alike?
inferredcites →https://doi.org/10.1002/2327-6924.12380openalex-snapshot
Understanding scoping reviews
inferredcites →https://doi.org/10.1016/j.ahj.2015.11.002openalex-snapshot
Supporting open access to clinical trial data for researchers: The Duke Clinical Research Institute–Bristol-Myers Squibb Supporting Open Access to Researchers Initiative
inferredcites →https://doi.org/10.1016/j.jclinepi.2021.02.003openalex-snapshot
Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement
inferredcites →https://doi.org/10.1016/s2589-7500(20)30273-9openalex-snapshot
Solutions to COVID-19 data sharing
inferredcites →https://doi.org/10.1017/9781108883511.024openalex-snapshot
Extension of the Transition Period under Article 66.1 of the TRIPS Agreement for Least-Developed Country Members for Certain Obligations with Respect to Pharmaceutical Products
inferredcites →https://doi.org/10.1017/dap.2020.9openalex-snapshot
The National Cancer Institute Cancer Moonshot Public Access and Data Sharing Policy—Initial assessment and implications
inferredcites →https://doi.org/10.1038/ng.3062openalex-snapshot
Data use under the NIH GWAS Data Sharing Policy and future directions
inferredcites →https://doi.org/10.1038/sdata.2018.268openalex-snapshot
Overview and experience of the YODA Project with clinical trial data sharing after 5 years
inferredcites →https://doi.org/10.1056/nejme1515172openalex-snapshot
Sharing Clinical Trial Data — A Proposal from the International Committee of Medical Journal Editors
inferredcites →https://doi.org/10.1056/nejmp1605378openalex-snapshot
From Patient to Patient — Sharing the Data from Clinical Trials
inferredcites →https://doi.org/10.1056/nejmsb0803929openalex-snapshot
Ethical and Scientific Implications of the Globalization of Clinical Research
inferredcites →https://doi.org/10.1056/nejmsr1302541openalex-snapshot
Access to Patient-Level Data from GlaxoSmithKline Clinical Trials
inferredcites →https://doi.org/10.1057/978-1-349-95988-4_648openalex-snapshot
National Institutes of Health
inferredcites →https://doi.org/10.1080/1364557032000119616openalex-snapshot
Scoping studies: towards a methodological framework
inferredcites →https://doi.org/10.1093/annonc/mdx123openalex-snapshot
Statistical controversies in clinical research: data access and sharing—can we be more transparent about clinical research? Let’s do what’s right for patients
inferredcites →https://doi.org/10.1093/nar/gkab417openalex-snapshot
The COVID-19 Data Portal: accelerating SARS-CoV-2 and COVID-19 research through rapid open access data sharing
inferredcites →https://doi.org/10.1111/j.1365-2125.1994.tb05705.xopenalex-snapshot
International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH).
inferredcites →https://doi.org/10.1111/j.1422-2213.2006.00308.xopenalex-snapshot
India's Product Patent Protection Regime: Less or More of “Pills for the Poor”?
inferredcites →https://doi.org/10.1136/ard.2007.080598openalex-snapshot
Ethical and legal constraints on data sharing between countries in multinational epidemiological studies in Europe report from a joint workshop of the European League Against Rheumatism standing committee on epidemiology with the “AutoCure project
inferredcites →https://doi.org/10.1136/bmj.e7381openalex-snapshot
How to achieve international action on falsified and substandard medicines
inferredcites →https://doi.org/10.1136/bmj.g4073openalex-snapshot
European Medicines Agency changes policy on clinical trial data publication
inferredcites →https://doi.org/10.1136/bmj.i5295openalex-snapshot
Beyond open data: realising the health benefits of sharing data: Table 1
inferredcites →https://doi.org/10.1136/bmj.k400openalex-snapshot
Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published inThe BMJandPLOS Medicine
inferredcites →https://doi.org/10.1136/bmj.n160openalex-snapshot
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
inferredcites →https://doi.org/10.1136/bmjopen-2017-018647openalex-snapshot
Sharing and reuse of individual participant data from clinical trials: principles and recommendations
inferredcites →https://doi.org/10.1136/bmjopen-2019-032334openalex-snapshot
Clinical trial data sharing: here’s the challenge
inferredcites →https://doi.org/10.1177/1556264615593494openalex-snapshot
Sharing Public Health Research Data
inferredcites →https://doi.org/10.1177/1556264615594606openalex-snapshot
Best Practices for Ethical Sharing of Individual-Level Health Research Data From Low- and Middle-Income Settings
inferredcites →https://doi.org/10.1177/1740774506073173openalex-snapshot
Clinical trials bureaucracy: unintended consequences of well-intentioned policy
inferredcites →https://doi.org/10.1186/1471-2288-13-48openalex-snapshot
Enhancing the scoping study methodology: a large, inter-professional team’s experience with Arksey and O’Malley’s framework
inferredcites →https://doi.org/10.1186/1745-6215-14-201openalex-snapshot
Sharing individual level data from observational studies and clinical trials: a perspective from NHLBI
inferredcites →https://doi.org/10.1186/1745-6215-16-s2-o1openalex-snapshot
Good practice principles for sharing individual participant data from publicly funded clinical trials
inferredcites →https://doi.org/10.1186/1748-5908-5-69openalex-snapshot
Scoping studies: advancing the methodology
inferredcites →https://doi.org/10.1186/s12874-017-0468-4openalex-snapshot
What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences
inferredcites →https://doi.org/10.1186/s13063-017-1816-8openalex-snapshot
Challenges to complete and useful data sharing
inferredcites →https://doi.org/10.1186/s13063-021-05104-zopenalex-snapshot
COVID-19 trials: declarations of data sharing intentions at trial registration and at publication
inferredcites →https://doi.org/10.1186/s41073-017-0028-9openalex-snapshot
What incentives increase data sharing in health and medical research? A systematic review
inferredcites →https://doi.org/10.12688/f1000research.13789.1openalex-snapshot
Classification of processes involved in sharing individual participant data from clinical trials
inferredcites →https://doi.org/10.1371/journal.pmed.1003844openalex-snapshot
Medical journal requirements for clinical trial data sharing: Ripe for improvement
inferredcites →https://doi.org/10.1371/journal.pone.0021101openalex-snapshot
Data Sharing by Scientists: Practices and Perceptions
inferredcites →https://doi.org/10.1377/hlthaff.2017.1558openalex-snapshot
Data Sharing For Precision Medicine: Policy Lessons And Future Directions
inferredcites →https://doi.org/10.20529/ijme.2006.047openalex-snapshot
The draft national pharmaceuticals policy: concerns relating to data exclusivity and price control
inferredcites →https://doi.org/10.2147/clep.s43118openalex-snapshot
Titles versus titles and abstracts for initial screening of articles for systematic reviews
inferredcites →https://doi.org/10.2196/22744openalex-snapshot
Opening a “Can of Worms” to Explore the Public's Hopes and Fears About Health Care Data Sharing: Qualitative Study
inferredcites →https://doi.org/10.4103/0019-5545.75542openalex-snapshot
Standard operating procedures for clinical practice
inferredcites →https://doi.org/10.7326/m15-2928openalex-snapshot
Sharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors
inferredcites →https://doi.org/10.7326/m17-1028openalex-snapshot
Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors
inferredcites →https://doi.org/10.7326/m18-0850openalex-snapshot
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4852168openalex-extracted
Digital Technology Ecotone to Revolutionize Health Sector
inferred← citeshttps://doi.org/10.1002/ijgo.14837openalex-snapshot
Integrity of randomized clinical trials: Performance of integrity tests and checklists requires assessment
inferred← citeshttps://doi.org/10.1007/978-3-031-58359-9_5openalex-snapshot
Digital Pathology Ecosystem: Basic Elements to Revolutionize the Diagnosis and Monitoring of Diseases in Health Sector
inferred← citeshttps://doi.org/10.1007/978-3-032-02936-2_9openalex-snapshot
ReDPT-CT: Designing Responsible Digital Process Twins for Clinical Trials
inferred← citeshttps://doi.org/10.1007/978-3-662-73259-5_16openalex-snapshot
Sekundäre Datenanalysen und Nutzung von Datenbanken in der klinischen Psychologie
inferred← citeshttps://doi.org/10.1007/s00210-025-04949-4openalex-snapshot
National-, institutional-, and individual-level determinants of pharmacology and pharmacy research excellence: an analysis of stanford–elsevier lists of the top 2% scholars (2017–2023)
inferred← citeshttps://doi.org/10.1016/j.craph.2025.100018openalex-snapshot
Critical perspectives on nanoparticle-enabled radiopharmaceuticals: Integrating molecular imaging, targeted therapy, and theranostic translation
inferred← citeshttps://doi.org/10.1016/j.eclinm.2025.103294openalex-snapshot
PEARLES challenges and solutions to the implementation of clinical research responses to epidemics and pandemics: a scoping review
inferred← citeshttps://doi.org/10.1016/j.isci.2023.106348openalex-snapshot
Open video data sharing in developmental science and clinical practice
inferred← citeshttps://doi.org/10.1016/j.jbi.2026.105096openalex-snapshot
A reinforcement learning approach to synthetic data generation
inferred← citeshttps://doi.org/10.1016/s2213-2600(24)00243-1openalex-snapshot
Compassionate use trials and equitable access to variant-specific treatment for cystic fibrosis
inferred← citeshttps://doi.org/10.1017/dap.2023.26openalex-snapshot
Individual participant data sharing intentions and practices during the coronavirus disease-2019 pandemic: A rapid review
inferred← citeshttps://doi.org/10.1089/neur.2023.0035openalex-snapshot
Perspectives on Data Sharing in Persons With Spinal Cord Injury
inferred← citeshttps://doi.org/10.1093/ckj/sfag201openalex-snapshot
Blockchain technology for secure and efficient nephrology data management
inferred← citeshttps://doi.org/10.1093/jamia/ocae024openalex-snapshot
Identifying the capabilities for creating next-generation registries: a guide for data leaders and a case for “registry science”
inferred← citeshttps://doi.org/10.1097/hep.0000000000001299openalex-snapshot
AI-driven synthetic data generation for accelerating hepatology research: A study of the United Network for Organ Sharing (UNOS) database
inferred← citeshttps://doi.org/10.1101/2025.07.07.25330987openalex-snapshot
Calibrating CONSORT-AI with FAIR Principles to enhance reproducibility in AI-driven clinical trials
inferred← citeshttps://doi.org/10.1136/bmjgh-2023-012007openalex-snapshot
Structural under-reporting of informed consent, data handling and sharing, ethical approval, and application of Open Science principles as proxies for study quality conduct in COVID-19 research: a systematic scoping review
inferred← citeshttps://doi.org/10.1136/bmjopen-2023-079621openalex-snapshot
Growing old before growing rich: a scoping review on ageing-related policy interventions from the WHO Southeast Asian Region
inferred← citeshttps://doi.org/10.1136/bmjopen-2025-101527openalex-snapshot
Global inequities in the adoption of innovative clinical trial designs: a cross-sectional analysis of ClinicalTrials.gov
inferred← citeshttps://doi.org/10.1142/s3060901125500061openalex-snapshot
Financial Technology-Enabled Sustainable Finance for Small- and Medium-Sized Enterprises
inferred← citeshttps://doi.org/10.1145/3807503.3819472openalex-snapshot
Federated Synthetic Data Generation for Hepatology Research: A UNOS based Evaluation
inferred← citeshttps://doi.org/10.1177/20552076251362097openalex-snapshot
Harnessing digital health technologies and real-world evidence to enhance clinical research and patient outcomes
inferred← citeshttps://doi.org/10.12688/f1000research.125893.1openalex-snapshot
Rapid review on monkeypox policies among the G20 nations: relevance to policy and practitioner
inferred← citeshttps://doi.org/10.1360/sst-2025-0048openalex-snapshot
Extended reality in neurology: Technological analysis and clinical value
inferred← citeshttps://doi.org/10.2196/preprints.37460openalex-snapshot
Individual Participant Data Sharing during the COVID-19 Pandemic: A Review of Individual Participant Data Sharing Intentions and Practices from Clinical Trials (Preprint)
inferred← citeshttps://doi.org/10.3233/shti230690openalex-snapshot
Reusing Biomedical Data as Agreed – Towards Structured Metadata for Data Use Agreements
inferred← citeshttps://doi.org/10.3389/fmed.2024.1408600openalex-snapshot
Ethical framework for FACILITATE: a foundation for the return of clinical trial data to participants
inferred← citeshttps://doi.org/10.3390/computers15040212openalex-snapshot
A Federated FHIR-Based Interoperability Framework for Multi-Site Heart Failure Monitoring: The RETENTION Project
inferred← citeshttps://doi.org/10.4018/979-8-2600-3753-9.ch016openalex-snapshot
Blueprints for Progress
inferred← citeshttps://doi.org/10.57187/s.3538openalex-snapshot
What are the bottlenecks to health data sharing in Switzerland? An interview study
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.